Roger Olofsson Bagge

Validating MIA & MSKCC predictive tool for melanoma sentinel node status 1:27
Validating MIA & MSKCC predictive tool for melanoma sentinel node status
Roger Olofsson Bagge • 4 Jun 2023
24 month OS results of the SCANDIUM trial 1:16
24 month OS results of the SCANDIUM trial
Roger Olofsson Bagge • 2 Jun 2023
SCANDIUM 2: IHP with ipilimumab and nivolumab in uveal melanoma metastases 0:49
SCANDIUM 2: IHP with ipilimumab and nivolumab in uveal melanoma metastases
Roger Olofsson Bagge • 2 Jun 2023
Current therapeutic options for uveal melanoma 0:34
Current therapeutic options for uveal melanoma
Roger Olofsson Bagge • 2 Jun 2023
Key findings from the FACT-M questionnaire in patients with melanoma 0:50
Key findings from the FACT-M questionnaire in patients with melanoma
Roger Olofsson Bagge • 5 Jun 2022
Treating uveal melanoma liver metastases with isolated hepatic perfusion 1:28
Treating uveal melanoma liver metastases with isolated hepatic perfusion
Roger Olofsson Bagge • 5 Jun 2022
Current and future treatment options for uveal melanoma 1:06
Current and future treatment options for uveal melanoma
Roger Olofsson Bagge • 5 Jun 2022
The efficacy of ICIs for melanoma in-transit nodal metastases with or without nodal metastasis 0:57
The efficacy of ICIs for melanoma in-transit nodal metastases with or without nodal metastasis
Roger Olofsson Bagge • 5 Jun 2022
The content of VJOncology is intended for healthcare professionals